Improvements in Stress, Affect, and Irritability Following Brief Use of a Mindfulness-based Smartphone App: A Randomized Controlled Trial – Economides et al, 2018

Available here - full text. One area which I reviewed as part of my foundation module in pain was Mindfulness and Mindfulness-Based Stress Reduction (MBSR) to see if there was any benefit for chronic pain sufferers. From what I found in a number of papers I reviewed was that pain scores do not change but acceptance of … Continue reading Improvements in Stress, Affect, and Irritability Following Brief Use of a Mindfulness-based Smartphone App: A Randomized Controlled Trial – Economides et al, 2018

Hall, Pippa, and Lynda Weaver. “Interdisciplinary education and teamwork: a long and winding road.” Medical education 35.9 (2001): 867-875

This article looks at education in an interdiscplinary team.  Most people have heard of a multi-disciplinary team where a team of specialists (in their own right) discuss cases.  Think of the MDT approach to hospital based disciplines and particualr complex cancer care.  At the other end of the spectrum is transdisciplinary where there is role … Continue reading Hall, Pippa, and Lynda Weaver. “Interdisciplinary education and teamwork: a long and winding road.” Medical education 35.9 (2001): 867-875

OSELTAMIVIR TREATMENT FOR INFLUENZA IN ADULTS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (Dobson et al., 2015)

I was interested to read about a new drug NICE have approved for HUS which by all accounts is massively expensive.  All sorts of harrumphing followed in the press as well as the medical press about funding of expensive drugs and QALYs.  Personally I think NICE have an important yet unforgiving job to do.  I … Continue reading OSELTAMIVIR TREATMENT FOR INFLUENZA IN ADULTS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (Dobson et al., 2015)

OSELTAMIVIR TREATMENT FOR INFLUENZA IN ADULTS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (Dobson et al., 2015)

I was interested to read about a new drug NICE have approved for HUS which by all accounts is massively expensive. All sorts of harrumphing followed in the press as well as the medical press about funding of expensive drugs and QALYs. Personally I think NICE have an important yet unforgiving job to do. I … Continue reading OSELTAMIVIR TREATMENT FOR INFLUENZA IN ADULTS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (Dobson et al., 2015)